XML 32 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Shareholders' Equity
6 Months Ended
Jun. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Shareholders' Equity

7. Shareholders’ Equity

Equity Compensation Plans

We have a stock plan (the “Stock Plan”) and an inducement stock plan for newly hired employees (together with the Stock Plan, the “Plans”). Under the Plans, stock options to purchase shares of our common stock may be granted with a fixed exercise price that is equal to the fair market value of our common stock on the date of grant. These options have a term of up to 10 years and vest over a predetermined period, generally four years. Incentive stock options granted under the Stock Plan may only be granted to our employees. The Plans also allow for awards of non-qualified stock options, stock appreciation rights, restricted and unrestricted stock awards, and RSUs.

Stock-Based Compensation

The estimated fair value of stock-based awards is recognized as compensation expense over the vesting period of the award, net of estimated forfeitures. We estimate forfeitures based on historical experience and expected future activity. The fair value of RSUs is determined based on the number of shares granted and the quoted price of our common stock on the date of grant. The fair value of stock option awards is estimated at the grant date based on the fair value of each vesting tranche as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. The BSM model requires various highly judgmental assumptions including expected volatility and option life. If any of the assumptions used in the BSM model change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. The fair values of our stock option grants were estimated with the following weighted average assumptions:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Expected life

 

5.2 years

 

 

3.3 years

 

 

5.3 years

 

 

3.3 years

 

Expected volatility

 

 

55

%

 

 

52

%

 

 

54

%

 

 

53

%

Risk-free interest rate

 

 

2.7

%

 

 

1.6

%

 

 

2.5

%

 

 

1.7

%

 

The impact on our results of operations from stock-based compensation expense was as follows (in thousands, except per share amounts):  

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Cost of revenue — professional engineering service

$

8

 

 

$

20

 

 

$

19

 

 

$

85

 

Selling, general and administrative

 

(80

)

 

 

320

 

 

 

184

 

 

 

604

 

Research and development

 

56

 

 

 

71

 

 

 

112

 

 

 

121

 

Total stock-based compensation expense

$

(16

)

 

$

411

 

 

$

315

 

 

$

810

 

Per diluted share

$

(0.00

)

 

$

0.03

 

 

$

0.02

 

 

$

0.06

 

 

Stock Option Activity

The following table summarizes stock option activity under the Plans:

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

Contractual Life

 

 

Aggregate

 

 

 

Number of Shares

 

 

Exercise Price

 

 

(in years)

 

 

Intrinsic Value

 

Balance at December 31, 2017

 

 

1,912,161

 

 

$

4.88

 

 

 

7.61

 

 

$

781,735

 

Granted

 

 

256,643

 

 

 

3.95

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2,422

)

 

 

3.59

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(265,697

)

 

 

4.90

 

 

 

 

 

 

 

 

 

Expired

 

 

(22,605

)

 

 

5.72

 

 

 

 

 

 

 

 

 

Balance at June 30, 2018

 

 

1,878,080

 

 

$

4.74

 

 

 

6.28

 

 

$

5,080

 

Vested and expected to vest at June 30, 2018

 

 

1,784,268

 

 

$

4.73

 

 

 

6.14

 

 

$

5,080

 

Exercisable at June 30, 2018

 

 

1,181,163

 

 

$

4.60

 

 

 

4.80

 

 

$

5,080

 

 

At June 30, 2018, total compensation cost related to stock options granted but not yet recognized was $745,000, net of estimated forfeitures. This cost will be amortized on the straight-line method over a weighted-average period of approximately 1.4 years. The following table summarizes certain information about stock options:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Weighted average grant-date fair value of options granted during the period

 

$

1.77

 

 

$

2.64

 

 

$

1.98

 

 

$

2.80

 

Options in-the-money (in shares)

 

 

19,550

 

 

 

1,755,762

 

 

 

19,550

 

 

 

1,755,762

 

Aggregate intrinsic value of options exercised during the period

 

$

1,578

 

 

$

17,412

 

 

$

1,853

 

 

$

57,833

 

 

The aggregate intrinsic value represents the difference between the exercise price of the underlying options and the quoted price of our common stock for the number of options that were exercised during the period. We issue new shares of common stock upon exercise of stock options.

Restricted Stock Unit Activity

The following table summarizes RSU activity under the Plans:

 

 

 

Number of

 

 

Weighted Average

 

 

 

Shares

 

 

Award Price

 

Unvested at December 31, 2017

 

 

116,968

 

 

$

5.33

 

Granted

 

 

136,505

 

 

 

3.21

 

Vested

 

 

(46,764

)

 

 

5.14

 

Forfeited

 

 

(26,312

)

 

 

5.31

 

Unvested at June 30, 2018

 

 

180,397

 

 

$

3.78

 

Expected to vest after June 30, 2018

 

 

165,730

 

 

$

3.75

 

 

At June 30, 2018, total compensation cost related to RSUs granted but not yet recognized was $433,000, net of estimated forfeitures. This cost will be amortized on the straight-line method over a weighted-average period of approximately 0.8 years.

Common Stock Reserved for Future Issuance

The following table summarizes our shares of common stock reserved for future issuance under the Plans as of June 30, 2018:

 

 

 

June 30, 2018

 

Stock options outstanding

 

 

1,878,080

 

Restricted stock units outstanding

 

 

180,397

 

Stock options available for future grant

 

 

1,110,722

 

Common stock reserved for future issuance

 

 

3,169,199